NEW YORK (AP) - In a story Sept. 20 about studies of a brand of insulin, The Associated Press reported erroneously that Sanofi-Aventis’ drug Lantus is co-marketed by drugmaker Bristol-Myers Squibb. The drug is marketed by Sanofi-Aventis alone.
Copyright © 2024 The Washington Times, LLC.
Please read our comment policy before commenting.